Breakthrough to Fight Antibiotic Resistance: The Biggest Threat of the 21st Century

Antibiotic resistance is possibly the biggest health crisis of the 21st century.

Recent statistics reveal that antibiotic-resistant "superbugs" claim at least 700,000 lives globally each year.

If left unchecked, these superbugs could kill up to 10 million people annually by 2050.

That would make them a leading cause of death, surpassing heart disease and even cancer.

Scientists worldwide are racing to find a solution.

And a small team of researchers might have discovered one...

A tiny company, in partnership with McMaster University, has developed a revolutionary technology that repels these deadly pathogens by 98%.

McMaster University has a history of success - their recent venture was acquired for $2.4 billion.

It could be the key to solving the superbug crisis and the next target of a major acquisition.

Click here to discover more about this potentially life-saving breakthrough.
Trust me, you don't want to miss out on this one.

This message is a paid advertisement for FendX Technologies Inc. (OTCMKTS: FDXTF) from i2i Marketing Group, LLC. It's Today Media, LLC. receives a fixed fee for each subscriber that clicks on a link in this email, totaling up to $7,500.00. Other than the compensation received for this advertisement sent to subscribers, It's Today Media and its principals are not affiliated with i2i Marketing Group, LLC. It's Today Media and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither It's Today Media nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from It's Today Media to buy or sell any security. It's Today Media has not evaluated the accuracy of any claims made in this advertisement. It's Today Media recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding FendX Technologies Inc. (OTCMKTS: FDXTF) on i2iMarketing Group's website for additional information about the relationship between i2i Marketing Group and FendX Technologies Inc. (OTCMKTS: FDXTF).